• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global multiple sclerosis therapies market experienced moderate growth during 2014-2019. Multiple sclerosis (MS) refers to a chronic and inflammatory immune-mediated condition that can cause demyelination, axonal transection and neurodegeneration of the nerve cells in the spinal cord and brain. Some of the commonly used therapies include the administration of injectable, oral and infused medicines, muscle relaxants, antidepressants and physical therapy. The injectable medication, such as Interferon-beta and Glatiramer acetate, are administered under the skin or into the muscle; oral medications include Dimethyl fumarate, Teriflunomide and Cladribine; and infusion treatments include Ocrelizumab, Natalizumab and Alemtuzumab, which are administered intravenously. These medicines aid in managing the symptoms to minimize the frequency of the relapses and control the heart rate and blood pressure of the patient.

The increasing prevalence of relapsing-remitting multiple sclerosis (RRMS), primary-progressive MS (PPMS), secondary-progressive MS (SPMS) and progressive-relapsing MS (PRMS) across the globe, is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Healthcare providers are widely using immunosuppressants that control autoimmune attacks and prevent relapses among patients suffering from MS. Additionally, various technological advancements, such as the development of innovative monoclonal bodies, immunomodulators, immunosuppressants and interferons for the effective treatment of MS, are acting as other major growth-inducing factors. Apart from this, governments of both the developed and emerging countries are launching campaigns to increase awareness regarding the available treatment alternatives among the masses, which, in turn, is creating a positive outlook for the market. Other factors, including extensive research and development (R&D) activities, along with the improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the global multiple sclerosis therapies market to continue its moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global multiple sclerosis therapies market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, drug, drug type, route of administration and distribution channel.

Breakup by Drug:

  • Immunomodulators
    • Copaxone
    • Avonex/Plegridy
    • Gilneya
    • Tysabri
    • Betaseron/Extavia
    • Tecifidera
    • Rebif
    • Ampyra
  • Immunosuppressants
    • Aubagio
    • Lemtrada
    • Ocrelizumab
    • Zinbryta
       

Breakup by Drug Type:

  • Biologic Drugs
  • Small Molecule Drugs
     

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Intravenous
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbvie Inc., Bayer Aktiengesellschaft, Biogen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG (Roche Holding AG), GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Sanofi S.A. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global multiple sclerosis therapies market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global multiple sclerosis therapies market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global multiple sclerosis therapies market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Multiple Sclerosis Therapies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug
    6.1    Immunomodulators
        6.1.1 Market Trends
        6.1.2 Major Types
              6.1.2.1 Copaxone
              6.1.2.2 Avonex/Plegridy
              6.1.2.3 Gilneya
              6.1.2.4 Tysabri
              6.1.2.5 Betaseron/Extavia
              6.1.2.6 Tecifidera
              6.1.2.7 Rebif
              6.1.2.8 Ampyra
        6.1.3 Market Forecast
    6.2    Immunosuppressants
        6.2.1 Market Trends
        6.2.2 Major Types
              6.1.2.1 Aubagio
              6.1.2.2 Lemtrada
              6.1.2.3 Ocrelizumab
              6.1.2.4 Zinbryta
        6.2.3 Market Forecast
7    Market Breakup by Drug Type
    7.1    Biologic Drugs
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Small Molecule Drugs
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Route of Administration
    8.1    Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectable
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Intravenous
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospitals Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Online Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbvie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials 
           15.3.1.4 SWOT Analysis
        15.3.2    Bayer Aktiengesellschaft
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials 
           15.3.2.4 SWOT Analysis
        15.3.3    Biogen Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials 
           15.3.3.4 SWOT Analysis
        15.3.4    Bristol-Myers Squibb Company
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials 
           15.3.4.4 SWOT Analysis
        15.3.5    F. Hoffmann-La Roche AG (Roche Holding AG)
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 SWOT Analysis
        15.3.6    GlaxoSmithKline Plc
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 Financials 
           15.3.6.4 SWOT Analysis
        15.3.7    Merck & Co. Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials 
           15.3.7.4 SWOT Analysis
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials 
           15.3.8.4 SWOT Analysis
        15.3.9    Sanofi S.A.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials 
           15.3.9.4 SWOT Analysis
        15.3.10    Teva Pharmaceutical Industries Ltd.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials 
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Multiple Sclerosis Therapies Market: Major Drivers and Challenges
Figure 2: Global: Multiple Sclerosis Therapies Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Multiple Sclerosis Therapies Market: Breakup by Drug (in %), 2019
Figure 4: Global: Multiple Sclerosis Therapies Market: Breakup by Drug Type (in %), 2019
Figure 5: Global: Multiple Sclerosis Therapies Market: Breakup by Route of Administration (in %), 2019
Figure 6: Global: Multiple Sclerosis Therapies Market: Breakup by Distribution Channel (in %), 2019
Figure 7: Global: Multiple Sclerosis Therapies Market: Breakup by Region (in %), 2019
Figure 8: Global: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 9: Global: Multiple Sclerosis Therapies (Immunomodulators) Market: Sales Value (in Million US$), 2014 & 2019
Figure 10: Global: Multiple Sclerosis Therapies (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 11: Global: Multiple Sclerosis Therapies (Immunosuppressants) Market: Sales Value (in Million US$), 2014 & 2019
Figure 12: Global: Multiple Sclerosis Therapies (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 13: Global: Multiple Sclerosis Therapies (Biologic Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Multiple Sclerosis Therapies (Biologic Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Multiple Sclerosis Therapies (Small Molecule Drugs) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Multiple Sclerosis Therapies (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Multiple Sclerosis Therapies (Oral) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Multiple Sclerosis Therapies (Oral) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Multiple Sclerosis Therapies (Injectable) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Multiple Sclerosis Therapies (Injectable) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Multiple Sclerosis Therapies (Intravenous) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Multiple Sclerosis Therapies (Intravenous) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Multiple Sclerosis Therapies (Hospital Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Multiple Sclerosis Therapies (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Multiple Sclerosis Therapies (Retail Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Multiple Sclerosis Therapies (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Multiple Sclerosis Therapies (Online Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Multiple Sclerosis Therapies (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: North America: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: North America: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: United States: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: United States: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Canada: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Canada: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Asia Pacific: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Asia Pacific: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: China: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: China: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Japan: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Japan: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: India: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: India: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: South Korea: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: South Korea: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Australia: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Australia: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Indonesia: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Indonesia: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Others: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Others: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Europe: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Europe: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Germany: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Germany: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: France: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: France: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: United Kingdom: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: United Kingdom: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Italy: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Italy: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Spain: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Spain: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Russia: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Russia: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Others: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Others: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Latin America: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Latin America: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Brazil: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Brazil: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Mexico: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Mexico: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Others: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Others: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Middle East and Africa: Multiple Sclerosis Therapies Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Middle East and Africa: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Global: Multiple Sclerosis Therapies Industry: SWOT Analysis
Figure 78: Global: Multiple Sclerosis Therapies Industry: Value Chain Analysis
Figure 79: Global: Multiple Sclerosis Therapies Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Multiple Sclerosis Therapies Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Drug (in Million US$), 2020-2025
Table 3: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Drug Type (in Million US$), 2020-2025
Table 4: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
Table 5: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Distribution Channel in Million US$), 2020-2025
Table 6: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 7: Global: Multiple Sclerosis Therapies Market Structure
Table 8: Global: Multiple Sclerosis Therapies Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links